Русский
The combined symptoms of male lower urinary tract: current treatment options
DOI: https://dx.doi.org/10.18565/urology.2018.4.135-141
Z.K. Gadzhieva, M.A. Gazimiev, Yu.B. Kazilov, V.A. Grigoryan
1I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia (Sechenov University), Moscow, Russia; 2Hospital of the MIA of the RF for the Republic of Dagestan, Makhachkala, Russia
This literature review presents current data on epidemiology and views on the pathogenesis of male lower urinary tract symptoms. The authors discuss current options for the management of male lower urinary tract symptoms using a fixed-dose combination drug that includes one of the most selective and safe α1-blockers tamsulosin OCAS and the most selective of anticholinergic agent solifenacin.
Keywords: anticholinergic, storage symptoms, Vezomni, voiding symptoms, α-blocker, lower urinary tract symptoms, tamsulosin, solifenacin
About the Autors
Corresponding author: Z. K. Gadzhieva – Dr.Med.Sci., Urologist at the UCH #2, I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University), Assistant to the Chairman of the RSU on Regional Affairs, Science Editor of the Journal Urologiia; e-mail: zgadzhieva@ooorou.ru
Similar Articles
